Category: News Floretina Icoor Meeting 2024

RETINA FUTURA 2024 CELEBRATES INNOVATION AND IMPACT IN RETINAL THERAPIES 

Florence, Italy, December 11, 2024 – Retina Futura is delighted to announce the winners of its prestigious awards, recognizing groundbreaking innovations and advancements in the treatment of retinal diseases. This year’s awards honor pioneering contributions that are shaping the future of ophthalmology and improving patient outcomes worldwide.

New Clinical and Nonclinical Analyses Reveal Silicone Oil is Associated With Intraocular Inflammation Following Intravitreal Administration of Abicipar Pegol

Peter K. Kaiser, MD of the Cole Eye Institute at the Cleveland Clinic in Cleveland, Ohio, presented an analysis of intraocular inflammation (IOI) risk factors following abicipar pegol treatment during the Late Breakers session at FLORetina on December 6, 2024.

Fas Inhibition with ONL1204 for the Treatment of Geographic Atrophy and Macula-OD

During the Retina Futura session at FLORetina on December 6, 2024, Lejla Vajzovic, MD, FASRS, Professor of Ophthalmology, Pediatrics, and Biomedical Engineering and Durga S. Borkar, MD, MMCi, Associate Professor of Ophthalmology], both from Duke University in Durham, North Carolina, presented results from two clinical studies evaluating the Fasinhibitor ONL1204 for treatment of Geographic Atrophy and Macula-OD Rhegmatogenous Retinal Detachment (RRD).